Fmnl1-KO Mouse
Common Name
Fmnl1-KO
제품 ID
S-KO-20013
Backgroud
C57BL/6JCya
품종 계통계통 ID
KOCMP-57778-Fmnl1-B6J-VB
상태
이 마우스 계통을 논문에서 사용할 경우, “Fmnl1-KO Mouse (카탈로그 번호 S-KO-20013)은 Cyagen에서 구입하였습니다.”라고 명시해 주시기 바랍니다.
구매 가능한 제품 종류
연령
Genotype
성별
수량
표준 제공 조건은 최소 3마리의 이형접합(heterozygous) 보균자를 보장합니다. 동형접합(homozygous) 보균자 및/또는 특정 성별에 대한 브리딩 서비스도 제공됩니다.
기본 정보
품종 계통
Fmnl1-KO
품종 계통계통 ID
KOCMP-57778-Fmnl1-B6J-VB
유전자명
제품 ID
S-KO-20013
유전자 별칭
Fmnl, Fnrl, Frls, 8030453N10Rik
배경
C57BL/6JCya
NCBI ID
변형 내용
Conventional knockout
염색체
Chr 11
Phenotype
Datasheet
적용 분야
--
품종 계통 설명
Ensembl 전사체 ID
ENSMUST00000042286
NCBI 전사체 ID
NM_001077698
타겟 영역
Exon 4~6
유효 영역 크기
~1.9 kb
유전자 연구 개요
Fmnl1, or Formin-like 1, belongs to the formin protein family responsible for cytoskeletal remodeling. It has been implicated in various cellular processes, such as cell migration, proliferation, and invasion, by interacting with signaling pathways like CXCR2, TGF-β1/SMADs, and Rac1 [1-3]. Fmnl1 is expressed in multiple cell types, including hematopoietic cells, T cells, and cancer cells, and is crucial for normal immune function and has significant implications in cancer progression. Genetic models, including gene-knockout (KO) models, are valuable for studying its functions.
In cancer, FMNL1 depletion in multiple cancer cell lines and in vivo models has shown significant impacts. In clear cell renal cell carcinoma (ccRCC), FMNL1 upregulation promotes metastasis via induction of CXCR2, and high expression is associated with poor prognosis. Knockdown of FMNL1 inhibits cell migration in vitro and tumor metastasis in vivo [1]. In non-small cell lung cancer (NSCLC), reducing FMNL1 expression suppresses cell proliferation, migration, invasion, and bone metastasis by reducing TGF-β1 expression [2]. In leukemia cells, FMNL1 depletion decreases cell proliferation, colony formation, migration, and tumor growth of xenografts, and its silencing increases Rac1 activity [3]. In nasopharyngeal carcinoma, depletion of FMNL1 suppresses invadopodia formation, epithelial-mesenchymal transition (EMT), and invasive/metastatic capacities [4]. In glioblastoma multiforme, FMNL1 downregulation suppresses cell migration and invasion, actin fiber assembly, and is an independent predictor of poor prognosis [5]. In breast adenocarcinoma, suppression of FMNL1 protein expression impairs cell adhesion, migration, and invasion [6].
In conclusion, Fmnl1 plays essential roles in cell migration, proliferation, and invasion, with significant implications in cancer progression. KO and other loss-of-function models have been instrumental in revealing these roles, highlighting Fmnl1 as a potential prognostic factor and therapeutic target in multiple cancer types. Additionally, Fmnl1 is associated with T cell migration in the immune system, indicating its broader importance in biological processes [1-4, 6, 7, 9].
References:
1. Zhang, Mei-Fang, Li, Qiu-Li, Yang, Yu-Feng, Cao, Yun, Zhang, Chris Zhiyi. 2020. FMNL1 Exhibits Pro-Metastatic Activity via CXCR2 in Clear Cell Renal Cell Carcinoma. In Frontiers in oncology, 10, 564614. doi:10.3389/fonc.2020.564614. https://pubmed.ncbi.nlm.nih.gov/33324547/
2. Yang, Xing-Yi, Liao, Jun-Jie, Xue, Wu-Rong. 2019. FMNL1 down-regulation suppresses bone metastasis through reducing TGF-β1 expression in non-small cell lung cancer (NSCLC). In Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 117, 109126. doi:10.1016/j.biopha.2019.109126. https://pubmed.ncbi.nlm.nih.gov/31387165/
3. Favaro, Patricia, Traina, Fabiola, Machado-Neto, João Agostinho, Ridley, Anne J, Saad, Sara Teresinha Olalla. 2013. FMNL1 promotes proliferation and migration of leukemia cells. In Journal of leukocyte biology, 94, 503-12. doi:10.1189/jlb.0113057. https://pubmed.ncbi.nlm.nih.gov/23801653/
4. Chen, Wen-Hui, Cai, Mu-Yan, Zhang, Jia-Xing, Qian, Chao-Nan, Xie, Dan. 2018. FMNL1 mediates nasopharyngeal carcinoma cell aggressiveness by epigenetically upregulating MTA1. In Oncogene, 37, 6243-6258. doi:10.1038/s41388-018-0351-8. https://pubmed.ncbi.nlm.nih.gov/30013189/
5. Higa, Nayuta, Shinsato, Yoshinari, Kamil, Muhammad, Yoshimoto, Koji, Arita, Kazunori. 2019. Formin-like 1 (FMNL1) Is Associated with Glioblastoma Multiforme Mesenchymal Subtype and Independently Predicts Poor Prognosis. In International journal of molecular sciences, 20, . doi:10.3390/ijms20246355. https://pubmed.ncbi.nlm.nih.gov/31861134/
6. Miller, Eric W, Blystone, Scott D. 2019. The carboxy-terminus of the formin FMNL1ɣ bundles actin to potentiate adenocarcinoma migration. In Journal of cellular biochemistry, 120, 14383-14404. doi:10.1002/jcb.28694. https://pubmed.ncbi.nlm.nih.gov/30977161/
품질 관리 기준
정자 검사
동결 보존 전: 정자 농도 측정 및 정자 생존율 평가.
동결 보존 후: 각 배치에서 동결 보존된 정자 바이알 1개를 선택하여 체외수정(in vitro fertilization)에 사용합니다.
Environmental Standards:
SPFAvailable Region:
GlobalSource:
Cyagen문의하기
맞춤형 동물 모델 관련 상담을 위해 Cyagen 전문가와 연락해 보세요. 아래 양식을 작성하여 상담을 시작하거나 견적을 요청하시기 바랍니다.
Cyagen은 고객님의 개인정보를 소중히 여깁니다. 최신 제품, 서비스 및 인사이트를 안내드리고자 합니다. 고객님의 수신 설정은 다음과 같습니다:
해당 커뮤니케이션은 언제든지 수신 거부하실 수 있습니다. 수신 거부 방법 및 데이터 보호에 대한 자세한 내용은 개인정보처리방침을 참고해 주시기 바랍니다.
아래 버튼을 클릭함으로써, 요청하신 콘텐츠 제공을 위해 본 양식을 통해 제출된 개인정보를 Cyagen이 저장 및 처리하는 데 동의하게 됩니다.
